Despite failing to achieve MRD-negativity after induction, patients with Ph+ acute lymphoblastic leukemia treated with ...

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results ...

Intermountain Health is now offering a national first-of-its kind expansion of CAR-T Cell Therapy, bringing cutting-edge ...

June 1 marks the final day of Sawyer Wobig’s treatment for B Cell Acute Lymphoblastic Leukemia. Sawyer, age 9, lives in ...

NEW YORK – The European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Autolus Therapeutics' autologous CD19-directed CAR T-cell therapy Aucatzyl ...

Huntsman Cancer Institute completed the first successful allogeneic stem cell transplant using cells from a deceased donor.

B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

Researchers sought to determine whether venetoclax plus low-intensity chemotherapy would be effective in adult patients with ALL.

A 10-year-old girl and her family from Barnstead are thanking blood donors and urging people to give because of the lifesaving treatment she has received. Lucy Bellemare had recurring fevers last year ...